Eli Lilly's stock dipped after drug trial results, but strong Q2 2025 earnings and market position make it a strong buy. Read ...

August 7, 2025Phathom Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.79 EPS, expectations were ...

Operator: Good morning. My name is Stephen, and I will be your conference operator today. I would like to welcome everyone to ...

Good day, and thank you for standing by. Welcome to the BuzzFeed Incorporated Second Quarter 2025 Earnings Conference Call.

GigaCloud Technology Inc. (NASDAQ: GCT) Q2 2025 Earnings Call Transcript August 7, 2025 GigaCloud Technology Inc. beats ...

Blue Owl Capital shows strong growth and AUM gains, but dilution and a premium valuation raise caution for investors. Find ...

Key Points GAAP revenue reached $2.44 billion in Q2 2025, rising 13.1% year over year (GAAP). Gross and operating margins declined significantly (GAAP), with gross margin down 1.6 percentage points.

Revenue climbed 22% (GAAP) for the three months ended June 30, 2025, compared to the prior year period, largely due to international growth in the Vycor Medical division. Non-GAAP operating profit ...

Assured Guaranty (AGO) reported Q2 financial results, with a call discussing new business, credit outlooks, market conditions ...

Backblaze just two quarters ago turned cash-flow-positive and expects to become GAAP net-income-positive within a few years, ...

Year-to-date Net Income has exceeded Adjusted Net Income by $4.1 million, as discrete items have lowered the effective tax ...